Search Results for "Relenza"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Relenza. Results 1 to 4 of 4 total matches.
See also: zanamivir

Comparison Table: Antiviral Drugs for Seasonal Influenza for 2025-2026 (online only)

   
The Medical Letter on Drugs and Therapeutics • Oct 27, 2025  (Issue 1740)
) ▪ Not FDA-approved for chemoprophylaxis 950.00 Zanamivir – Relenza (GSK) 5 mg blisters of powder ...
View the Comparison Table: Antiviral Drugs for Seasonal Influenza for 2025-2026
Med Lett Drugs Ther. 2025 Oct 27;67(1740):e178-80   doi:10.58347/tml.2025.1740d |  Show IntroductionHide Introduction

Drugs Past Their Expiration Date

   
The Medical Letter on Drugs and Therapeutics • Jan 05, 2026  (Issue 1745)
to use the antiviral drugs Tamiflu (oseltamivir; 75-mg capsules) and Relenza (zanamivir inhalation ...
Healthcare providers are often asked if drugs can be used past their expiration date. Because of legal restrictions and liability concerns, manufacturers do not sanction such use and usually do not comment on the safety or effectiveness of their products beyond the date on the label. Since our last article on this subject, more data have become available.
Med Lett Drugs Ther. 2026 Jan 5;68(1745):5-7   doi:10.58347/tml.2026.1745c |  Show IntroductionHide Introduction

Antiviral Drugs for Seasonal Influenza for 2025-2026

   
The Medical Letter on Drugs and Therapeutics • Oct 27, 2025  (Issue 1740)
of severe influenza10 Not FDA-approved for chemoprophylaxis 950.00 Zanamivir – Relenza (GSK) 5 mg ...
Influenza is generally a self-limited illness, but complications including pneumonia, respiratory failure, and death can occur, especially in persons at increased risk (see Table 1).
Med Lett Drugs Ther. 2025 Oct 27;67(1740):169-74   doi:10.58347/tml.2025.1740a |  Show IntroductionHide Introduction

Influenza Vaccines for 2025-2026

   
The Medical Letter on Drugs and Therapeutics • Sep 29, 2025  (Issue 1738)
, and generics) or zanamivir (Relenza) within 48 hours before, peramivir (Rapivab) within 5 days before ...
Annual vaccination against influenza A and B viruses is recommended in the US for everyone ≥6 months old without a contraindication. Influenza vaccines available in the US for the 2025-2026 season are listed in Table 2.
Med Lett Drugs Ther. 2025 Sep 29;67(1738):153-8   doi:10.58347/tml.2025.1738a |  Show IntroductionHide Introduction